Crossmark

Immunotherapy for migraine: The use of erenumab in real life

Crossref DOI link: https://doi.org/10.1016/j.rceng.2020.07.007

Published Print: 2021-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez-Marín, B.

Heredia Ledesma, D.

Lizarralde Álvarez, A.

Grasa Ullrich, J.M.
License Information

Text and Data Mining valid from 2021-11-01
More Information

This article is maintained by: Elsevier

Article Title: Immunotherapy for migraine: The use of erenumab in real life

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2020.07.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2020.07.004

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.